Johnson Financial Group LLC Buys Shares of 1,672 Danaher Corporation (NYSE:DHR)

Key Points

• Johnson Financial Group LLC acquired a new stake in Danaher Corporation by purchasing 1,672 shares valued at approximately $343,000 in the first quarter.
• Danaher reported a quarterly earnings per share (EPS) of $1.80, surpassing expectations of $1.64, along with a revenue of $5.94 billion, reflecting a 3.4% year-over-year increase.
• The company's stock has an average rating of “Moderate Buy” from analysts, with a consensus target price of $247.61 despite some analysts lowering their target prices.

Johnson Financial Group LLC bought a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,672 shares of the conglomerate's stock, valued at approximately $343,000.

Several other large investors have also recently bought and sold shares of the business. GAMMA Investing LLC increased its position in Danaher by 24,958.2% in the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after purchasing an additional 1,863,381 shares during the last quarter. Two Sigma Advisers LP increased its holdings in Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after buying an additional 1,601,800 shares during the last quarter. Capital World Investors raised its position in Danaher by 32.7% during the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after acquiring an additional 1,566,658 shares in the last quarter. Point72 Asset Management L.P. lifted its stake in Danaher by 460.6% in the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after acquiring an additional 1,107,998 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Danaher in the fourth quarter worth approximately $242,837,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 3.0%

Shares of DHR traded up $6.03 during trading hours on Tuesday, hitting $205.79. 2,829,956 shares of the stock traded hands, compared to its average volume of 4,270,321. The business has a fifty day moving average of $198.68 and a 200-day moving average of $200.30. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $147.36 billion, a PE ratio of 43.79, a price-to-earnings-growth ratio of 2.80 and a beta of 0.73. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 EPS. Analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Analyst Ratings Changes

Several research firms have commented on DHR. UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Evercore ISI cut their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Barclays restated an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.